Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Kyoto Drug Discovery and Development produces drugs for rare eye diseases using novel compounds.
Stem Cell & Device Laboratory is aiming to contribute to a healthy society with new cell application products.
Cleanhearing is a manufacturing company that provides non-invasive medical devices for tinnitus treatment and management.
Oligogen is a biotech startup developing stem cell technologies that provides therapies for patients with central nervous system diseases.
The world's first audio-only metaverse.
PrediXT is a developer of prediction technologies.
Kyoto University Innovation Capital has invested in 78 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Kyoto University Innovation Capital's top investment sectors include Health Care, Manufacturing, Medical Device, Pharmaceutical, Product Research. The firm invests across 20 different industry categories.
Among tracked funding rounds, Stem Cell & Device Laboratory received $4.5M in a Series B round. Kyoto University Innovation Capital's total known invested capital is $180.1M.
Kyoto University Innovation Capital's average investment size is $2.8M across its portfolio of 78 companies.